GlassScriptPhysician profile
Sean Tarride
NPI 1821481011
$1,305.33
in general payments reported to CMS, 2019-2025
27 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $57.56 · 2021: $139 · 2022: $345 · 2023: $306 · 2024: $145 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $235.47 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $176.15 | 2023-2025 | Veozah |
| Gynesonics, INC. | $117.60 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $99.42 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $70.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $53.67 | 2019-2022 | |
| Organon LLC | $48.83 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $47.49 | 2023 | |
| Sage Therapeutics, LLC | $44.30 | 2022 | |
| Pfizer INC. | $42.81 | 2023-2024 | |
| Smith+Nephew, INC. | $42.57 | 2021 | |
| Biogen, INC. | $42.10 | 2022-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $36.35 | 2023 | Myfembree |
| Medtronic, INC. | $35.55 | 2022 | |
| Kci USA, INC. | $27.05 | 2022-2023 | Prevena |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.25 | 2019-2020 | |
| Novo Nordisk INC | $18.11 | 2023 | |
| Therapeuticsmd, INC. | $17.90 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.63 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $16.63 | 2022 | |
| Hologic Sales and Service, LLC | $16.44 | 2023 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $15.00 | 2019 | |
| Meditrina | $14.53 | 2022 | |
| Gilead Sciences, INC. | $14.03 | 2025 | |
| Avion Pharmaceuticals | $12.97 | 2022 | |
| Avanos Medical | $11.74 | 2020 | |
| Allotrope Medical, INC | $6.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Tarride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.